Roche Diagnostics India wins Frost & Sullivan 2021 India leadership award
Equipment

Roche Diagnostics India wins Frost & Sullivan 2021 India leadership award

Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making

  • By IPP Bureau | March 14, 2022

The Indian in vitro diagnostics (IVD) market, has grown exponentially over the years and in appreciation of the comendable work done by Roche Diagnostics, Frost & Sullivan recognizes the company's efforts with the 2021 India Competitive Strategy Leadership Award for its well-executed country strategies, effective market penetration, and innovative offerings.

Each year, Frost & Sullivan presents this award to the company that leverages competitive intelligence to successfully execute a strategy that results in stronger market share, competitive brand positioning, and customer satisfaction.

Roche Diagnostics gained a foothold in the fragmented Indian market by strategically targeting underdeveloped cities. Its technology-led solutions significantly improved operational efficiency, result quality, and turnaround time to provide exceptional value for diverse stakeholders.

"While other global market participants are hesitant to enter the price-sensitive Indian IVD industry, Roche Diagnostics strategically segregated and introduced its latest products and technologies to distinct segments, penetrating and shaping the country's IVD space," said Ojaswi Rana, Best Practices Research Analyst for Frost & Sullivan. "Prioritizing market share over profitability, it specifically addressed the needs of Tier II and Tier III cities, thereby accelerating access to diagnostics in the country. Its model includes warehouses in different parts of India to provide easier access to customers instead of establishing a consolidated warehouse."

As one of the industry's biggest research and development spenders, Roche Diagnostics globally has a robust end-to-end diagnostic portfolio. It provides blood safety, clinical chemistry, companion diagnostics, custom biotech, laboratory automation and software solutions, and molecular diagnostics services. Roche also offers HPV DNA testing to detect the probability of cervical cancer, enabling patients to receive timely treatment and prevent its progression.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

Upcoming E-conference

Other Related stories

Startup

Digitization